About ICRI
Leading the global effort to advance evidence-based cannabis research, education, and policy for the benefit of patients and society.
Our Mission
The International Cannabis Research Institute (ICRI) is dedicated to advancing the scientific understanding of cannabis and cannabinoids through rigorous research, comprehensive education, and evidence-based policy advocacy.
We work to bridge the gap between emerging cannabis science and practical applications, ensuring that patients, healthcare providers, and policymakers have access to accurate, up-to-date information grounded in robust scientific evidence.
Our Vision
We envision a world where cannabis and cannabinoid therapies are understood, accessible, and utilized based on sound scientific evidence. Through collaborative research and education, we strive to transform cannabis from a controversial substance into a well-researched therapeutic option.
Our vision includes establishing global standards for cannabis research, fostering international collaboration, and ensuring that policy decisions are informed by the best available scientific evidence.
Our Values
Guiding principles that shape our work and commitment to excellence.
Scientific Rigor
Upholding the highest standards of research methodology and evidence-based practice.
Patient-Centered
Prioritizing patient safety, wellbeing, and access to evidence-based cannabis medicine.
Collaboration
Building partnerships across disciplines, institutions, and borders to advance knowledge.
Integrity
Maintaining transparency, ethical standards, and objectivity in all our work.
Our Impact
Making a difference through research, education, and advocacy.
Our Team
Meet the dedicated scientists and experts driving cannabis research forward.
Dr. Sarah Mitchell
Dr. Mitchell brings over 20 years of experience in cannabinoid pharmacology and has published extensively on therapeutic applications of cannabis. She holds a Ph.D. in Pharmacology from Stanford University and previously served as Director of Cannabinoid Research at a major academic medical center.
Dr. James Thompson
Dr. Thompson is a leading expert in clinical trials and cannabinoid therapeutics. With a background in neurology and pain medicine, he oversees ICRI's clinical research portfolio and collaborates with research institutions worldwide. He completed his medical training at Johns Hopkins University.
Dr. Maria Garcia
Dr. Garcia develops evidence-based educational programs for healthcare professionals and the public. She holds a Ph.D. in Public Health from UC Berkeley and has extensive experience in medical education and health communication, particularly in emerging therapeutic areas.
Dr. Robert Chen
Dr. Chen bridges the gap between cannabis science and public policy. With expertise in health policy and regulatory science, he works with policymakers worldwide to develop evidence-based cannabis regulations. He earned his J.D. and Ph.D. from Harvard University.
Dr. Aisha Patel
Dr. Patel specializes in cannabinoid chemistry and analytical methods. Her research focuses on understanding the pharmacological properties of various cannabinoids and developing standardized testing protocols. She completed her postdoctoral training at MIT.
Dr. Michael O'Brien
Dr. O'Brien manages ICRI's clinical trial operations and ensures adherence to regulatory requirements and ethical standards. With a background in clinical research management and biostatistics, he brings rigor and efficiency to our research programs.
Join Our Mission
Partner with us to advance evidence-based cannabis research and make a lasting impact on global health.
Explore Partnership Opportunities